Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Atnahs Pharma UK Limited, Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, United Kingdom
Naprosyn 500mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Naprosyn 500mg Tablets: Oblong, yellow uncoated tablet embossed “NPR LE 500” on one face with a breakline on the other. |
Naprosyn 500mg Tablets: Each tablet contains 500mg naproxen.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Naproxen |
Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. |
| List of Excipients |
|---|
|
Povidone |
Clear or opaque PVC blister packaging with aluminium lidding in cartons, containing 56 tablets.
Atnahs Pharma UK Limited, Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, United Kingdom
PL 43252/0005
Date of first authorisation: 31 May 1996
Date of latest renewal: 09 February 2009
| Drug | Countries | |
|---|---|---|
| NAPROSYN | Australia, Canada, Ecuador, Estonia, Spain, Ireland, Italy, Malta, New Zealand, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
